Abstract
We evaluated the possible anticancer performance of a natural compound, goniothalamin (GTN), against human lung cancer using as a non-small cell lung cancer (NSCLC) cell line, H1299, as the model system. Cellular proliferation was significantly inhibited by GTN. Using an improved alkaline comet-nuclear extract (comet-NE) assay, GTN was found to induce a significant increase in the tail DNA. Wound healing and zymography assays showed that GTN attenuated cell migration and caused a reduction in the activity level of two major migration-associated matrix metalloproteinases, MMP-2 and MMP-9. It can be concluded that the DNA-damaging effect of GTN against lung cancer cells leads to growth inhibition as well as a depression in migration ability. Therefore, GTN has potential as a chemotherapeutic agent against lung cancer.
| Original language | English |
|---|---|
| Pages (from-to) | 4288-4293 |
| Number of pages | 6 |
| Journal | Journal of Agricultural and Food Chemistry |
| Volume | 59 |
| Issue number | 8 |
| DOIs | |
| Publication status | Published - 2011 Apr 27 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Goniothalamin
- cell migration
- comet assay
- matrix metalloproteinase
- non-small cell lung cancer
ASJC Scopus subject areas
- General Chemistry
- General Agricultural and Biological Sciences
Fingerprint
Dive into the research topics of 'Goniothalamin inhibits growth of human lung cancer cells through DNA damage, apoptosis, and reduced migration ability'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS